Publications by authors named "Jennifer Claytor"

Anastomotic inflammatory polyps are a known source of gastrointestinal bleeding in patients who have undergone bowel resection, but an anastomotic spindle cell sarcoma with myogenic differentiation has never been reported. We present the case of a patient with occult gastrointestinal bleeding 6 years after an ileocolic resection for an incarcerated hernia and discuss surveillance in patients with these rare polyps.

View Article and Find Full Text PDF

Background: Pouchitis is common among patients with ulcerative colitis (UC) who have had colectomy with ileal pouch-anal anastomosis. Antibiotics are first-line therapy for pouch inflammation, increasing the potential for gut colonization with multi-drug resistant organisms (MDRO). Fecal microbial transplant (FMT) is being studied in the treatment of pouchitis and in the eradication of MDRO.

View Article and Find Full Text PDF
Article Synopsis
  • - The rising rates of inflammatory bowel diseases (IBDs) like Crohn's and ulcerative colitis are leading to significant healthcare costs ranging from $9,000 to $12,000 per year in wealthy areas, but this doesn't fully capture factors like disease severity and regional healthcare differences.
  • - Indirect costs from lost productivity due to IBD are substantial yet often underestimated, and challenges such as access disparities and lack of standardized care guidelines complicate efforts to manage costs effectively.
  • - To make IBD care sustainable, strategies like using biologic therapies early, increasing access to biosimilars, and implementing multidisciplinary care teams with a focus on technology and patient feedback are essential for improving outcomes and reducing financial burdens.
View Article and Find Full Text PDF

Purpose Of Review: Crohn's Disease (CD) is a chronic inflammatory disease that can lead to progressive damage to the gastrointestinal tract and significant disability. Early, "top-down" biologic therapy is recommended in moderate-to-severe CD to induce remission and to prevent hospitalization and complications. However, an estimated 20-30% of patients with CD have a mild disease course and may not garner sufficient benefit from expensive, immunosuppressing agents to justify their risks.

View Article and Find Full Text PDF
Article Synopsis
  • The study discusses the risks of starting biologic therapies for rheumatologic disorders without conducting prior HIV screening, highlighting cases where patients were discovered to have undiagnosed HIV after starting treatment.* -
  • Three patient cases are analyzed: a 53-year-old man with rheumatoid arthritis, a 55-year-old woman with hidradenitis suppurativa, and a 32-year-old man with inflammatory bowel disease, all of whom faced complications after beginning biologic therapy.* -
  • Each case demonstrated that undiagnosed HIV infection led to unexpected health issues and complications related to their conditions, emphasizing the need for routine HIV screening before initiating immunosuppressive treatments.*
View Article and Find Full Text PDF

Objectives: To determine risk factors for body image dissatisfaction among pediatric patients with inflammatory bowel disease (IBD).

Study Design: We performed a cross-sectional study of children aged 9-18 years in the IBD Partners Kids & Teens cohort. Participants completed surveys including demographics, disease characteristics and activity indices, and psychosocial outcomes measured by IMPACT-III questionnaires.

View Article and Find Full Text PDF

Purpose Of Review: The purpose of this brief review is to investigate the current utility of fecal microbial transplantation (FMT) to ameliorate dysbiosis contributing to inflammatory bowel disease pathogenesis.

Recent Findings: Increasing data from randomized, controlled trials support a role for multiple FMT administrations in the induction of remission and even as a maintenance therapy in mild-to-moderate Ulcerative Colitis. Small series and one small randomized controlled trial among patients with Crohn's Disease and with pouchitis continue to produce conflicting clinical results and microbial profile data on the host and donor levels.

View Article and Find Full Text PDF

Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) represents a spectrum of rare but severe mucocutaneous drug reactions. Gastrointestinal involvement of SJS/TEN is associated with high morbidity and mortality and often presents 2-3 weeks after the initial appearance of skin lesions. There are no evidence-based treatment algorithms for the management of SJS/TEN.

View Article and Find Full Text PDF